Rachel Würstlein – CDK4/6 inhibitor in invasive disease-free survival of breast cancer patients

What is the most common side effects of Abemaciclib?

This site is only for use by healthcare professionals.

By continuing to view this site you are confirming that you are a healthcare professional.

Confirm